Meridian Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-710
Closed -$229K 109
2024
Q3
$229K Sell
710
-103
-13% -$33.7K 0.04% 94
2024
Q2
$254K Buy
813
+53
+7% +$15.6K 0.04% 89
2024
Q1
$216K Buy
760
+9
+1% +$2.63K 0.04% 95
2023
Q4
$216K Buy
+751
New +$205K 0.04% 94
2021
Q2
Sell
-511
Closed -$127K 139
2021
Q1
$127K Buy
511
+17
+3% +$4.06K 0.04% 92
2020
Q4
$113K Sell
494
-10
-2% -$2.31K 0.05% 90
2020
Q3
$129K Buy
504
+3
+0.6% +$743 0.07% 76
2020
Q2
$119K Buy
501
+7
+1% +$1.6K 0.06% 81
2020
Q1
$100K Buy
494
+114
+30% +$24.9K 0.06% 85
2019
Q4
$92K Buy
+380
New +$83.8K 0.06% 96

Other funds holding AMGN

Meridian Wealth Partners's AMGN Position: Q4 2024 in Review

Meridian Wealth Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 710 shares — an estimated $229K sold.

Meridian Wealth Partners first reported a position in AMGN in Q4 2019 and held it in 10 quarters. The position peaked at $254K in Q2 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Meridian Wealth Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Meridian Wealth Partners sold 710 Amgen shares in Q4 2024, an estimated $229K.
  • Meridian Wealth Partners first reported a position in Amgen in Q4 2019 and held it in 10 quarters.
  • Meridian Wealth Partners's Amgen position peaked at $254K in Q2 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Meridian Wealth Partners's 13F filing for Q4 2024, filed 11 Feb 2025.